Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography
<i>Background and Objectives</i>: Serotonin modulates platelet aggregation and secretion, but its role in hemostasis remains controversial. This study hypothesized that the 5-HT<sub>3</sub> receptor antagonist palonosetron may inhibit platelet function and aimed to evaluate i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/4/682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850180531998687232 |
|---|---|
| author | Hyun-Jung Shin Bon-Wook Koo Ji-Na Kim Ji-In Park Hyo-Seok Na |
| author_facet | Hyun-Jung Shin Bon-Wook Koo Ji-Na Kim Ji-In Park Hyo-Seok Na |
| author_sort | Hyun-Jung Shin |
| collection | DOAJ |
| description | <i>Background and Objectives</i>: Serotonin modulates platelet aggregation and secretion, but its role in hemostasis remains controversial. This study hypothesized that the 5-HT<sub>3</sub> receptor antagonist palonosetron may inhibit platelet function and aimed to evaluate its effects on blood coagulation using thromboelastography (TEG). <i>Materials and Methods</i>: Blood samples from 11 healthy volunteers were treated with palonosetron at concentrations of 25, 250, and 2500 ng/mL. Untreated samples served as controls. Coagulation parameters were assessed using global hemostasis (citrated kaolin, citrated rapid TEG, citrated kaolin with heparinase, and citrated functional fibrinogen) and PlateletMapping (adenosine diphosphate [ADP], arachidonic acid, and others) assays. <i>Results</i>: In the global hemostasis assay, maximum amplitude values, reflecting clot strength, decreased with increasing palonosetron concentrations in all tests, including citrated kaolin (<i>p</i> = 0.031), citrated rapid TEG (<i>p</i> = 0.001), citrated kaolin with heparinase (<i>p</i> = 0.033), and citrated functional fibrinogen (<i>p</i> = 0.011). The PlateletMapping assay showed significant reductions in ADP-induced platelet aggregation (<i>p</i> = 0.001), with the largest inhibition observed at 2500 ng/mL (<i>p</i> = 0.007). Despite these changes, all values remained within normal reference ranges. <i>Conclusions</i>: Palonosetron induces hypocoagulable trends in vitro by inhibiting platelet function and fibrinogen-mediated clot strength. However, these changes are unlikely to result in clinically significant hemostatic impairment when used within therapeutic doses. Further research is warranted to confirm these findings and explore their clinical relevance. |
| format | Article |
| id | doaj-art-b543d86bf9f940458bb0437047be3739 |
| institution | OA Journals |
| issn | 1010-660X 1648-9144 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj-art-b543d86bf9f940458bb0437047be37392025-08-20T02:18:09ZengMDPI AGMedicina1010-660X1648-91442025-04-0161468210.3390/medicina61040682Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using ThromboelastographyHyun-Jung Shin0Bon-Wook Koo1Ji-Na Kim2Ji-In Park3Hyo-Seok Na4Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaDepartment of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea<i>Background and Objectives</i>: Serotonin modulates platelet aggregation and secretion, but its role in hemostasis remains controversial. This study hypothesized that the 5-HT<sub>3</sub> receptor antagonist palonosetron may inhibit platelet function and aimed to evaluate its effects on blood coagulation using thromboelastography (TEG). <i>Materials and Methods</i>: Blood samples from 11 healthy volunteers were treated with palonosetron at concentrations of 25, 250, and 2500 ng/mL. Untreated samples served as controls. Coagulation parameters were assessed using global hemostasis (citrated kaolin, citrated rapid TEG, citrated kaolin with heparinase, and citrated functional fibrinogen) and PlateletMapping (adenosine diphosphate [ADP], arachidonic acid, and others) assays. <i>Results</i>: In the global hemostasis assay, maximum amplitude values, reflecting clot strength, decreased with increasing palonosetron concentrations in all tests, including citrated kaolin (<i>p</i> = 0.031), citrated rapid TEG (<i>p</i> = 0.001), citrated kaolin with heparinase (<i>p</i> = 0.033), and citrated functional fibrinogen (<i>p</i> = 0.011). The PlateletMapping assay showed significant reductions in ADP-induced platelet aggregation (<i>p</i> = 0.001), with the largest inhibition observed at 2500 ng/mL (<i>p</i> = 0.007). Despite these changes, all values remained within normal reference ranges. <i>Conclusions</i>: Palonosetron induces hypocoagulable trends in vitro by inhibiting platelet function and fibrinogen-mediated clot strength. However, these changes are unlikely to result in clinically significant hemostatic impairment when used within therapeutic doses. Further research is warranted to confirm these findings and explore their clinical relevance.https://www.mdpi.com/1648-9144/61/4/682palonosetronplatelet functionthromboelastographyhemostasis5-HT<sub>3</sub> receptor antagonistserotonin |
| spellingShingle | Hyun-Jung Shin Bon-Wook Koo Ji-Na Kim Ji-In Park Hyo-Seok Na Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography Medicina palonosetron platelet function thromboelastography hemostasis 5-HT<sub>3</sub> receptor antagonist serotonin |
| title | Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography |
| title_full | Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography |
| title_fullStr | Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography |
| title_full_unstemmed | Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography |
| title_short | Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography |
| title_sort | effects of the 5 hydroxytryptamine 3 receptor antagonist palonosetron on hemostasis an in vitro study using thromboelastography |
| topic | palonosetron platelet function thromboelastography hemostasis 5-HT<sub>3</sub> receptor antagonist serotonin |
| url | https://www.mdpi.com/1648-9144/61/4/682 |
| work_keys_str_mv | AT hyunjungshin effectsofthe5hydroxytryptamine3receptorantagonistpalonosetrononhemostasisaninvitrostudyusingthromboelastography AT bonwookkoo effectsofthe5hydroxytryptamine3receptorantagonistpalonosetrononhemostasisaninvitrostudyusingthromboelastography AT jinakim effectsofthe5hydroxytryptamine3receptorantagonistpalonosetrononhemostasisaninvitrostudyusingthromboelastography AT jiinpark effectsofthe5hydroxytryptamine3receptorantagonistpalonosetrononhemostasisaninvitrostudyusingthromboelastography AT hyoseokna effectsofthe5hydroxytryptamine3receptorantagonistpalonosetrononhemostasisaninvitrostudyusingthromboelastography |